SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-020754
Filing Date
2017-04-17
Accepted
2017-04-17 17:23:15
Documents
73
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v464066_10k.htm 10-K 1007922
2 EXHIBIT 21.1 v464066_ex21-1.htm EX-21.1 4601
3 EXHIBIT 23.1 v464066_ex23-1.htm EX-23.1 3264
4 EXHIBIT 31.1 v464066_ex31-1.htm EX-31.1 11819
5 EXHIBIT 32.1 v464066_ex32-1.htm EX-32.1 6462
  Complete submission text file 0001144204-17-020754.txt   7927857

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nwbo-20161231.xml EX-101.INS 1714382
7 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20161231.xsd EX-101.SCH 77169
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20161231_cal.xml EX-101.CAL 58110
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20161231_def.xml EX-101.DEF 496370
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20161231_lab.xml EX-101.LAB 529308
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20161231_pre.xml EX-101.PRE 537295
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35737 | Film No.: 17765344
SIC: 2834 Pharmaceutical Preparations